Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T20:58:43.600Z.
Calculation as of: 2026-10-06T20:58:43.600Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d6bc5587bb9f90acc5d4b17d4ca5e7b82419962628673aeee65b4bef0dd46512
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
SciSparc Ltd.
Market Cap
$250443.00
EV/EBIT Ratio
N/A
Market Cap
$29771.00
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| SciSparc Ltd. (SPRC) | $250443.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61172.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29771.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
